Skip to main content

PGD conditions

This table shows all PGD conditions currently approved and awaiting consideration by the HFEA.

Please note that we are updating this database, and some approved conditions may not be displayed. If you are unsure if a condition has been approved or not, please contact pgd@hfea.gov.uk.

Condition name Status OMIM number Documents
Pyrodoxine-dependent seizures (EPD) approved 266100
Pyruvate dehydrogenase E1-alpha deficiency X-linked approved 312170
Pyruvate Dehydrogenase E1-beta Deficiency approved 614111
Pyruvate Dehydrogenase, Alpha-1 (PDHA1) approved 312170
Rapp-Hodgkin Syndrome (RHS) approved 129400
Recurrent Digynic Triploidy approved
Recurrent hydatidiform mole (HYDM1) approved 231090
Recurrent infections with encephalopathy, hepatic dysfunction and cardiovascular malformations (FADD deficiency) approved 613759
Renal cell carcinoma, papillary, 1 (RCCP1) approved 605074
Renal Coloboma Syndrome approved 120330
Renal Cysts and Diabetes (RCAD) approved 137920
Retinal macular dystrophy 2 approved 608051
Retinitis Pigmentosa (autosomal dominant) approved 180100
Retinitis Pigmentosa (RP3) (x-linked) approved 300029
Retinitis Pigmentosa (x-linked) approved 300455
Retinitis pigmentosa 2 (RP2) approved 312600
Retinitis Pigmentosa Type 11 (RP11) approved 600138
Retinitis Pigmentosa type 7 (RP7) approved 608133
Retinoblastoma (RB1) approved 180200
Rett Syndrome (RTT) and Neonatal Encephalopathy approved 312750, 300673